Clinical trial
MyLeukoMAP™ Genomic Survival Prediction Assay for Heart Failure Pivotal Clinical Study
NCT05258942 is registered in ClinicalTrials.gov with LeukoLifeDx Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MyLeukoMAP™ Genomic Survival Prediction Assay for Heart Failure Pivotal Clinical Study
- Lead sponsor
- LeukoLifeDx Inc
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 1, 2022
- Completion date
- August 31, 2023
- Enrollment
- 300 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.